Geode Capital Management, LLC Rigel Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.12 - $1.57 $111,776 - $156,686	99,800 Added 2.7%	3,792,499 $5.61 Million
Q4 2023 Feb 13, 2024	BUY	$0.72 - $1.56 $104,831 - $227,134	145,599 Added 4.1%	3,692,699 $5.35 Million
Q3 2023 Nov 13, 2023	BUY	$1.07 - $1.39 $149,853 - $194,669	140,050 Added 4.11%	3,547,100 $3.83 Million
Q2 2023 Aug 11, 2023	BUY	$1.12 - $1.82 $148,354 - $241,075	132,459 Added 4.05%	3,407,050 $4.4 Million
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $156,401 - $250,242	125,121 Added 3.97%	3,274,591 $4.32 Million
Q4 2022 Feb 13, 2023	BUY	$0.67 - $11.9 $42,251 - $750,437	63,062 Added 2.04%	3,149,470 $4.72 Million
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $19,743 - $218,977	17,949 Added 0.58%	3,086,408 $3.64 Million
Q2 2022 Aug 12, 2022	BUY	$0.67 - $3.19 $5,849 - $27,851	8,731 Added 0.29%	3,068,459 $3.47 Million
Q1 2022 May 13, 2022	SELL	$2.22 - $3.45 $117,509 - $182,615	-52,932 Reduced 1.7%	3,059,728 $9.15 Million
Q4 2021 Feb 11, 2022	BUY	$2.36 - $3.57 $16,803 - $25,418	7,120 Added 0.23%	3,112,660 $8.25 Million
Q3 2021 Nov 12, 2021	BUY	$3.5 - $4.5 $442,449 - $568,863	126,414 Added 4.24%	3,105,540 $11.3 Million
Q2 2021 Aug 13, 2021	BUY	$3.09 - $4.54 $575,324 - $845,298	186,189 Added 6.67%	2,979,126 $12.9 Million
Q1 2021 May 12, 2021	BUY	$3.35 - $4.93 $645,293 - $949,641	192,625 Added 7.41%	2,792,937 $9.55 Million
Q4 2020 Feb 12, 2021	BUY	$2.35 - $3.74 $109,737 - $174,646	46,697 Added 1.83%	2,600,312 $9.1 Million
Q3 2020 Nov 13, 2020	BUY	$1.78 - $4.13 $96,540 - $223,994	54,236 Added 2.17%	2,553,615 $6.13 Million
Q2 2020 Aug 13, 2020	BUY	$1.41 - $2.05 $92,775 - $134,885	65,798 Added 2.7%	2,499,379 $4.57 Million
Q1 2020 May 14, 2020	BUY	$1.27 - $3.0 $221,394 - $522,978	174,326 Added 7.72%	2,433,581 $3.8 Million
Q4 2019 Feb 13, 2020	SELL	$1.6 - $2.43 $122,576 - $186,162	-76,610 Reduced 3.28%	2,259,255 $4.83 Million
Q3 2019 Nov 12, 2019	BUY	$1.63 - $2.62 $38,647 - $62,120	23,710 Added 1.03%	2,335,865 $4.37 Million
Q2 2019 Aug 14, 2019	BUY	$2.02 - $2.61 $569,084 - $735,302	281,725 Added 13.88%	2,312,155 $6.03 Million
Q1 2019 May 14, 2019	BUY	$2.0 - $2.65 $202,484 - $268,291	101,242 Added 5.25%	2,030,430 $5.22 Million
Q4 2018 Feb 13, 2019	BUY	$2.08 - $3.36 $581,185 - $938,837	279,416 Added 16.94%	1,929,188 $4.44 Million
Q3 2018 Nov 13, 2018	BUY	$2.6 - $3.59 $3,949 - $5,453	1,519 Added 0.09%	1,649,772 $5.3 Million
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $1.06 Million - $1.53 Million	373,149 Added 29.26%	1,648,253 $4.66 Million
Q1 2018 May 15, 2018	BUY	$3.54 - $4.54 $91,062 - $116,786	25,724 Added 2.06%	1,275,104 $4.51 Million
Q4 2017 Feb 13, 2018	BUY	$3.23 - $4.3 $632,692 - $842,284	195,880 Added 18.59%	1,249,380 $4.85 Million
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $48,241 - $56,871	22,129 Added 2.15%	1,053,500 $2.68 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,031,371	1,031,371 $2.82 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account